Food & Function · 2020 · 45 citations · 27 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyMetabolic RegulationCardiometabolic Risk ReductionCardiovascular DiseaseHypertension ManagementMetabolic SyndromeOral ProbioticsProbioticsAutonomic Function AssessmentAutonomic Function MonitoringAutonomic Nervous System ModulationCardiometabolic DiseaseProbiotic Effects On AbsorptionProbiotic FunctionalityProbiotic PropertiesProbiotic Supplements
BACKGROUND AND AIMS: We assessed the effects of probiotic therapy for 8 weeks on cardiometabolic variables and autonomic function in women medically diagnosed with arterial hypertension. METHODS AND RESULTS: Forty women with arterial hypertension, 20-50 years, were assigned to two groups in this randomized, triple-blind, placebo-controlled clinical trial. Patients in the probiotic group received a daily sachet containing Lactobacillus para casei LPC-37, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM, and Bifidobacterium lactis HN019 (109 CFU of each strain) for 8 weeks. Patients in the placebo group received identical sachets with polydextrose (1 g day-1, for 8 weeks). Anthropometric, BP, electrocardiogram, biochemical measurements, fecal microbiota composition, and glucose hydrogen breath test were assessed at baseline and after 8 weeks intervention. Anthropometric variables (weight, BMI, and waist circumference) were similar between the two groups (p > 0.05). Probiotic supplementation significantly reduced fasting glucose (change -10.3 mg dL-1, p < 0.05) and cholesterol levels (change -23.6 mg dL-1, p < 0.05), and increased the HDL-cholesterol (change 6.5 mg dL-1, p < 0.05) compared with the baseline condition. Probiotic supplementation lowered, although without statistical significance, systolic BP by about 5 mmHg and diastolic BP by about 2 mmHg in hypertensive women. Lastly, probiotic administration reduced the low frequency (LF) oscillation and LF/high frequency (HF) ratio (p < 0.05) in the frequency domain of heart rate variability, suggesting an improvement in autonomic modulation. CONCLUSION: Probiotic therapy for 8 weeks reduced fasting glucose levels, and improved the lipid profile and autonomic modulation in hypertensive women.
27
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li, Fangqing Zhao, Yidan Wang et al. · Microbiome · 2017 · 1.7K citations · Full text
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events
Hisako Tsuji, Martin G. Larson, Ferdinand J. Venditti et al. · Circulation · 1996 · 1.7K citations
Gut Dysbiosis Is Linked to Hypertension
Tao Yang, Monica M. Santisteban, Vermalí Rodríguez et al. · Hypertension · 2015 · 1.5K citations · Full text
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Xiuying Zhang, Dongqian Shen, Zhiwei Fang et al. · PLoS ONE · 2013 · 966 citations · Full text